Ninjin'yoeito, a herbal medicine, enhances glucose tolerance in mice
- PMID: 33895618
- DOI: 10.1016/j.npep.2021.102150
Ninjin'yoeito, a herbal medicine, enhances glucose tolerance in mice
Abstract
The prevalence of Type 2 diabetes increases under conditions of obesity but also due to aging. While a variety of treatment options are being explored there are still many unanswered questions about the underlying mechanisms for the aetiology and progression of this illness. Here we show that pre-treatment with Ninjin'yoeito (NYT), a herbal medicine composed of 12 different ingrediencies, before a glucose challenge results in significantly improved glucose tolerance. This occurs in the absence of significant alterations in insulin excursion compared to vehicle treatment, indicating NYT improves insulin responsiveness and/or insulin-independent glucose disposal. Furthermore, we identify Ginseng - one of the 12 ingredients of NYT - as one key component contributing to NYT's effect on glucose clearance. Importantly, lack of Y4 receptor signalling abolishes the positive effects of NYT on glucose tolerance suggesting Y4 receptor-controlled pathways are crucial in mediating this action of NYT. Using c-fos as neuronal activation marker, we show NYT activates the area postrema - a circumventricular organ in the brainstem that expresses high level of Y4 receptors, supporting an involvement of brainstem Y4 signalling in NYT-activated central networks. Together, these data suggest that NYT is a positive influencer of glucose metabolism in insulin-sensitive tissues and the mechanistic actions of NYT include brainstem Y4 circuitries.
Keywords: Brainstem; Glucose tolerance; Insulin action; NPY; Ninjin'yoeito; Y4.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.J Ethnopharmacol. 2021 Oct 28;279:114332. doi: 10.1016/j.jep.2021.114332. Epub 2021 Jun 12. J Ethnopharmacol. 2021. PMID: 34129897
-
Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2).Int J Clin Oncol. 2020 Jun;25(6):1123-1129. doi: 10.1007/s10147-020-01648-3. Epub 2020 Mar 30. Int J Clin Oncol. 2020. PMID: 32232692 Clinical Trial.
-
Effect of ninjin'yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice.J Nat Med. 2017 Oct;71(4):757-764. doi: 10.1007/s11418-017-1113-6. Epub 2017 Jul 10. J Nat Med. 2017. PMID: 28695397
-
Ninjin'yoeito modulates feeding and activity under negative energy balance conditions via the NPY system.Neuropeptides. 2021 Jun;87:102149. doi: 10.1016/j.npep.2021.102149. Epub 2021 Apr 15. Neuropeptides. 2021. PMID: 33882337 Review.
-
Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2019 Sep 2;2019:9590260. doi: 10.1155/2019/9590260. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31565066 Free PMC article. Review.
Cited by
-
Frailty and the Correlation Between Total Testosterone Levels and Urinary Incontinence Among Elderly Women.Int Urogynecol J. 2024 Sep;35(9):1909-1919. doi: 10.1007/s00192-024-05906-0. Epub 2024 Aug 31. Int Urogynecol J. 2024. PMID: 39215809
-
Molecular Mechanisms of Obesity-Induced Development of Insulin Resistance and Promotion of Amyloid-β Accumulation: Dietary Therapy Using Weak Organic Acids via Improvement of Lowered Interstitial Fluid pH.Biomolecules. 2023 Apr 30;13(5):779. doi: 10.3390/biom13050779. Biomolecules. 2023. PMID: 37238649 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous